News & Events about Cytosorbents Corp.
StockNews.com lowered shares of Cytosorbents (NASDAQ:CTSO Get Rating) from a hold rating to a sell rating in a research note released on Thursday. Separately, HC Wainwright decreased their target price on Cytosorbents from $9.00 to $5.50 and set a buy rating for the company in a research ...
StockNews.com upgraded shares of Cytosorbents (NASDAQ:CTSO Get Rating) from a sell rating to a hold rating in a research report report published on Thursday morning. Separately, HC Wainwright cut their price objective on Cytosorbents from $9.00 to $5.50 and set a buy rating on the stock in a...
Cytosorbents Corp (NASDAQ: CTSO)shares are trading higher by 15.55% to $1.38 Thursday afternoon after the company announced it received $5 million in non-dilutive debt financing from Bridge Bank and extended a loan agreement.
What's Happening?
read more...
CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement CytoSorbents Receives $5M in Non-Dilutive Debt Financing from Bridge Bank and Extends Loan Agreement PR Newswire PRINCETON, N.J., Dec. 29, 2022 Non-dilutive debt capital at market favorable terms...
CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without Modifications CytoSorbents Receives Recommendation from Independent Data and Safety Monitoring Board to Continue Pivotal STAR-T Trial As Planned Without...